The bill also makes it more difficult to access care, and implements hugely restrictive regulations on abortion clinics, which could force many of them to close their doors.
The 5th Circuit’s ruling maintains mifepristone’s availability for now, but severely limits access in ways that could harm patients seeking abortion care.
Access to the abortion medication mifepristone has been called into question following the issuance of competing rulings in Texas and Washington.
| October 29, 2025
| October 20, 2025
| October 7, 2025
| September 12, 2025
| August 27, 2025
